![Chris Picardo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Picardo
Direttore/Membro del Consiglio presso Modulus Therapeutics, Inc.
Profilo
Chris Picardo is currently working as a Director at Life Science Washington and Modulus Therapeutics, Inc. He completed his undergraduate degree from Williams College.
Posizioni attive di Chris Picardo
Società | Posizione | Inizio |
---|---|---|
Modulus Therapeutics, Inc.
![]() Modulus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020. | Direttore/Membro del Consiglio | - |
Life Science Washington | Direttore/Membro del Consiglio | 11/01/2022 |
Formazione di Chris Picardo
Williams College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Life Science Washington | |
Modulus Therapeutics, Inc.
![]() Modulus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020. | Commercial Services |
- Borsa valori
- Insiders
- Chris Picardo